Lobbying Filing Details

Total Spending

$20,000

Activities

5

Lobbyists

5

Gov't Entities

10

Filing Information
Filing UUID:
b8393d3f-736a-4acd-889d-a3fd42c04fac
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 8:17 PM
Income:
$20,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Alisa Hess
Registrant
ALPINE GROUP PARTNERS, LLC.

Public relations consulting firm

Washington, District of Columbia
Client
CARL ZEISS, INC.

Optics manufacturing company

New York, United States of America
Lobbying Activities (5)
Activity 1
Health Issues

Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care

Foreign Entity Issues: As indicated in the registration, company is headquartered in Germany

Lobbyists (5)
  • RHOD SHAW
  • MICHAEL SEAN HAYWOOD
  • CURTIS PHILIP
  • COLIN BRAINARD
  • ERIN MENDELSOHN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Manufacturing

Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care

Foreign Entity Issues: As indicated in the registration, company is headquartered in Germany

Lobbyists (5)
  • RHOD SHAW
  • MICHAEL SEAN HAYWOOD
  • CURTIS PHILIP
  • COLIN BRAINARD
  • ERIN MENDELSOHN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Science/Technology

Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care

Foreign Entity Issues: As indicated in the registration, company is headquartered in Germany

Lobbyists (5)
  • RHOD SHAW
  • MICHAEL SEAN HAYWOOD
  • CURTIS PHILIP
  • COLIN BRAINARD
  • ERIN MENDELSOHN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Trade (domestic/foreign)

Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care

Foreign Entity Issues: As indicated in the registration, company is headquartered in Germany

Lobbyists (5)
  • RHOD SHAW
  • MICHAEL SEAN HAYWOOD
  • CURTIS PHILIP
  • COLIN BRAINARD
  • ERIN MENDELSOHN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 5
Waste (hazardous/solid/interstate/nuclear)

Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care

Foreign Entity Issues: As indicated in the registration, company is headquartered in Germany

Lobbyists (5)
  • RHOD SHAW
  • MICHAEL SEAN HAYWOOD
  • CURTIS PHILIP
  • COLIN BRAINARD
  • ERIN MENDELSOHN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.